Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Highfield Biopharmaceuticals Corporation

Clinical trials sponsored by Highfield Biopharmaceuticals Corporation, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Smart chemo: new drug aims to hit HER-2 cancers harder Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 1

New liposome drug takes aim at Hard-to-Treat cancers

Disease control Not yet recruiting

This early-stage trial tests a new drug called HF50 in 45 adults with advanced solid tumors that have not responded to standard treatments. HF50 is designed to target HER2 on cancer cells and boost the immune system. The main goals are to check safety, find the right dose, and se…

Phase 1 • Sponsor: HighField Biopharmaceuticals Corporation • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC